Prognosis in Takayasu's arteritis is limited owing to renovascular hypertension. The authors report a patient with Takayasu's arteritis who had been unilaterally nephrec tomized and presented with malignant hypertension due to renal artery stenosis. Hypertension was refractory to conventional antihypertensive treatment, and stenosis was not accessible by interventional angioplasty. Initiation of enalapril and losartan therapy was successful in improving blood pressure without deterioration of renal function due to ischemic failure. Antihypertensive treatment resulted in dramatically stimulated endogenous nitric oxide (NO) synthesis, while elevated plasma endothelin-1 levels were unchanged. Renovascular hypertension in Takayasu's arteritis is associated with an imbalance of vasoconstrictor peptide endothelin-1 and vasodilator peptide NO. Successful treatment of hypertension by enalapril or losartan results in improved endoge nous NO synthesis, which putatively counterbalances excessive vasoconstrictor actions and may retard the progression of renal failure.
Get full access to this article
View all access options for this article.
References
1.
Schrire V., Asherson RA: Arteritis of the aorta and its major branches. Q J Med132: 439-462, 1964.
2.
Sharma BK, Sagar S., Singh AP, et al: Takayasu's arteritis in India. Heart Vessels7 (suppl) :37-43, 1992.
3.
Ooi BS, Chen Btm, Yu SF, et al: Primary arteritis of the aorta as a cause of renovascular hypertension in Singapore. Aust NZ J Med1:132-136, 1971.
Park YB, Hong SK, Choi KJ, et al: Takayasu arteritis in Korea: Clinical and angiographic features . Heart Vessels7(suppl):55-59, 1992.
8.
Hall S., Barr MD, Lie JT, et al: Takayasu arteritis: A study of 32 North American patients. Medicine64:89-99, 1985.
9.
Ishikawa K.: Natural history and classification of occlusive thromboaortopathy (Takayasu's disease). Circulation57:27-35, 1978.
10.
Hata A., Noda M., Moriwaki R., et al: Angiographic findings of Takayasu arteritis: New classification . Int J Cardiol54:S155-S163, 1996.
11.
Ishikawa K. : Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu's arteriopathy. J Am Coll Cardiol12:964-972, 1988.
12.
Sharma BK, Iliskovic NS, Singal PK: Takayasu arteritis may be underdiagnosed in North America. Can J Cardiol11:311-316, 1995.
13.
Arend WP, Michel BA, Bloch DA, et al: The American College of Rheumatology 1990 criteria for the classification of Takayasu's arteritis. Arthritis Rheum33:1129-1134, 1990.
14.
Lupi Herrera E., Torres GS, Marcushamer J., et al: Takayasu arteritis: Clinical study of 107 cases. Am Heart J93:94-103, 1977.
15.
Yamato M., Lecky JW, Hiramatsu K., et al: Takayasu arteritis: Radiographic and angiographic findings in 59 patients. Radiology161:329-334, 1986.
16.
Subramanyan R., Joy J., Balakrishnan KG: Natural history of aortoarteritis (Takayasu's disease). Circulation80:429-437, 1989.
17.
Hoffman GS, Leavitt RY, Kerr GS, et al: Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate. Arthritis Rheum37:578-582, 1994.
18.
Shelhamer JH , Volkman DJ, Parrillo JE, et al: Takayasu's arteritis and its therapy . Ann Intern Med103:121-126, 1985.
19.
Numano F., Maruyama Y., Koyama T., et al: Antiaggregatory aspirin dosage at the affected vessel wall. Angiology37:695-701, 1986.
20.
Giordano JM , Leavitt RY, Hoffman G., et al: Experience with surgical treatment of Takayasu's disease. Surgery109:252-258, 1991.
21.
Kumar S., Mandalam KR, Rao VR, et al: Percutaneous transluminal angioplasty in non-specific aortoarteritis (Takayasu's disease): Experience of 16 cases. Cardiovasc Intervent Radiol12:321-325, 1989.
22.
Lüscher TF: Imbalance of endothelium-derived relaxing and contracting factors. A new concept in hypertension?Am J Hypertens3:317-330, 1990.
23.
Ito H., Hirata Y., Hiroe M., et al: Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. Circ Res69:209-215, 1991.
24.
Garg UC, Hassid A.: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest83 :1774-1777, 1989.
25.
Arnal J-F., Yamin J., Dockery S., et al: Regulation of endothelial nitric oxide synthase mRNA, protein, and activity during cell growth. Am J Physiol267:C1381-1388, 1994.
Akazawa H., Ikeda U., Kuroda T., et al: Plasma endothelin-1 levels in Takayasu's arteritis. Cardiology87:303-305, 1996.
28.
Uyama O., Nagatsuka K., Nakamura M., et al: Plasma concentrations of 6-keto-prostaglandin F1 alpha in patients with hypertension, cerebrovascular disease or Takayasu's arteritis. Thromb Res25:71-79, 1982.
29.
Momose N., Kukuo K., Morimoto S., et al: Captopril inhibits endothelin-1 secretion from endothelial cells through bradykinin. Hypertension21:921-924, 1993.
30.
Bakris GL, Bhandaru S., Akerstrom V., et al: ACE inhibitor-mediated attenuation of mesangial cell growth . A role for endothelin. Am J Hypertens7:583-590, 1994.
31.
Auch-Schwelk W., Duske E., Claus M., et al: Endothelium-mediated vasodilation during ACE inhibition. Eur Heart J16(suppl C) :59-65, 1995.
32.
Warren JB, Loi RK: Captopril increases skin microvascular blood flow secondary to bradykinin, nitric oxide, and prostaglandins. FASEB J9:411-418, 1995.
33.
Kahler J., Baldus S., Varendorff TV, et al: Captopril reduces endothelin-1 release from human umbilical vein endothelial cells by reduction of angiotensin II synthesis. J Am Coll Cardiol27(suppl A):104A, 1996 (abstract).
34.
Maeso R., Rodrigo E., Munoz-Garcia R., et al: Losartan reduces constrictor responses to endothelin-1 and the thromboxane A2 analogue in aortic rings from spontaneously hypertensive rats: Role of nitric oxide. J Hypertens15:1677-1684, 1997.
